REFERENCES
- Alavarez, E., Perez, V., Dragheim, M., Loft, H., & Artigas, F. (2012). A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patient with major depressive disorder. International Journal of Neuropsychopharmacology, 15, 589–600. doi: 10.1017/S1461145711001027
- Auclair, A. L., Martel, J. C., Assié, M. B., Bardin, L., Heusler, P., Cussac, D., … Depoortère, R. (2013). Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety. Neuropharmacology, 70, 338–347.
- Bang-Anderson, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., … Stensbøl, T. B. (2011). Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A novel multimodal compound for the treatment of major depressive disorder. Journal of Medicinal Chemistry, 54, 3206–3221.
- Boulenger, J., Loft, H., & Florea, I. (2012). A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder. Journal of Psychopharmacology, 26(11), 1408–1416. doi :10.1177/0269881112441866
- Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
- Forest Laboratories, Inc. (2014). Fetzima. Retrieved from http://medlibrary. org/lib/rx/meds/fetzima/
- Glennon, R. A., Dukat, M., & Westkaemper, R. B. (2002). Serotonin receptor subtypes and ligands… In: Davis, K. L., Charney, D., Coyle, J. T., Nemeroff, C. (Eds). Philadelphia: Lippincott Williams & Wilkins.
- Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62. doi: 10.1136/jnnp.23.1.56 PMID 14399272
- Malenka, R. (2010). Intercellular communication in the nervous system. Waltham, MA: Academic.
- Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134(4), 382–389. doi: 10.1192/bjp.134.4.382 PMID 444788
- National Alliance on Mental Illness. (2013a). Vortioxetine. Retrieved from http://www.nami.org/Template.cfm?Section=Helpline1&Template=/Content Management/ContentDisplay.cfm&ContentID=164493
- National Alliance on Mental Illness. (2013b). Levomilnacipran. Retrieved from http://www.nami.org/Template.cfm?Section=Helpline1&Template=/Content Management/ContentDisplay.cfm&ContentID=164486
- Saraceni, M. M., Venci, J. V., & Gandhi, M. A. (2013, December 31). Levomilnacipran (Fetzima): A new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder. Journal of Pharmacy Practice. doi: 10.1177/0897190013516504
- Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.
- Takeda Pharmaceuticals. (2013, September). Brintellix package insert. Conshohocken, PA: Author.